secwatch.observer — SEC 8-K summary
======================================

Issuer:     SELECT MEDICAL HOLDINGS CORP (SEM)
CIK:        0001320414
Form:       8-K
Filed at:   2025-12-19T23:59:59+00:00
Accession:  0001104659-25-123153
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Select Medical enters new CEO employment agreement with Thomas Mullin effective Jan 1, 2026
--------------------------------------------------------------------------------

- 1-year initial term, auto-renewing; base salary $700,000/year.
- Termination without cause: 12 months base salary continuation.
- Non-compete and non-solicitation covenants apply for 2 years post-termination.
- Change of control terms governed by prior February 2021 letter.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1320414/000110465925123153/0001104659-25-123153-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1320414/000110465925123153/tm2533937d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-123153

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer